Clinical Trials Browser

Adenocarcinoma of Lung

NCT04119024 2026-03-17

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

BreastCNSDermatologicEndocrineHead & NeckNETThoracic

Adenocarcinoma of Lung, Squamous Cell Carcinoma of Head and Neck, Uveal Melanoma, Breast Neoplasms, Adenoma, Islet Cell, Melanoma, Neoplasm Metastasis, Paraganglioma, Pheochromocytoma, Thyroid Neoplasms, Adrenocortical Carcinoma, Neuroendocrine Tumors

Clinical Trials

KETO-FDG Lung

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

Pleural Effusion Biomarkers in Lung Adenocarcinoma Patients

EVLC

Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Chemotherapy in Treating Patients With Stage II-III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery

Partial Tumor Irradiation and Immunotherapy for Unresectable Lung Cancer

BLCIO

Testing the Safety of Dapagliflozin Prior to Surgery for the Treatment of Patients With Stage IA Lung Adenocarcinoma

CRYOMUNE

Using Biomarkers for Diagnosis, Risk Stratification of Post -Treatment Recurrence and Long-Term Surveillance of Lung Cancer

Evaluation of Different Sizes of Left-Sided Double-Lumen Tubes for Thoracic Surgery in a Tertiary Level Teaching Hospital

Nivolumab and Ipilimumab With or Without Local Consolidation Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer

ALDH

An Investigational Scan (Me-4FDG PET/CT) for the Detection of Sodium-Glucose Transport for Early Diagnosis of Lung Cancer

Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer

RESET

STAR012

RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial

A Study of Tumor-Treating Fields (TTFields) in People With Lung Adenocarcinoma

Testing the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 70 Years of Age and Older With Advanced Non-small Cell Lung Cancer

DNA Methylation Biomarkers to Predict Survival After Surgery for Lung Adenocarcinoma

Shared Decision Making in Patients With Lung Cancer

Comparison Paravertebral and Serratus Anterior Plane Block in Video-assisted Thoracoscopic Surgery.

Pathogenic Variants in Genes Associated With Lung Adenocarcinoma

Sleep State in Lung Cancer: A Retrospective Analysis

CAR T Cells in Mesothelin Expressing Cancers

Defactinib, Avutometinib and Nivolumab for the Treatment of Anti-PD1 Refractory LKB1-Mutant Advanced Non-Small Cell Lung Cancer

Lorlatinib Compared with Concurrent/ Sequential Chemoradiotherapy in Stage III ALK Positive Lung Adenocarcinoma

Clinical Application of PET Imaging Targeting MSLN in Malignant Tumors

Primary Tumor Resection With EGFR TKI for Stage IV NSCLC

OOTER

18F-FDG and 68Ga-FAPI PET/CT in Lung Adenocarcinoma

TEG

Lung Cancer Mutation Consortium Protocol

Lymph Node Pathologic Grading Strategy

Plasma Exosomes Reveal the Efficacy of Targeted Therapy in Patients With EGFR Mutation in Lung Adenocarcinoma

Vinorelbine and Bevacizumab in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

WSI Based DL for Diagnosing the IASLC Grading System of Lung Adenocarcinoma

Retrospective Analysis of Clinical and CT Features to Predict Spread Through Air Space in Stage IA Lung Adenocarcinoma

Segmentectomy for Solid-dominant Lung Cancer

TP53 R248Q TCR-T Cell Therapy for Advanced Solid Tumor

CORIN

Improving the Intraoperative Diagnosis Accuracy of Invasiveness for Small-sized Lung Adenocarcinoma

Reinforced and Non-Reinforced Staple Lines in Fissureless Lobectomy

SCION

Intraoperative Frozen Section Pathology to Diagnose the IASLC Grades for Lung Adenocarcinoma (ECTOP-1014)

AUTOMAN

Adjuvant Benmelstobart for Stage IB, Grade 3 Invasive Lung Adenocarcinoma

LungBrain001

Cios Mobile 3D Spin for Robotic Bronchoscopy